Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uterine Neoplasms”

4,204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,204 results

Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Testing effectiveness (Phase 2)UnknownNCT03567655
What this trial is testing

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Asan Medical Center 41
Testing effectiveness (Phase 2)Study completedNCT00087685
What this trial is testing

RAD001 in Recurrent Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT03665285
What this trial is testing

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more
NextCure, Inc. 109
Early research (Phase 1)Active Not RecruitingNCT04188548
What this trial is testing

LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more
Eli Lilly and Company 500
Not applicableStudy completedNCT02367625
What this trial is testing

Performance, Safety, and Efficacy of a New Cyrotherapy Device for Cervical Dysplasia

Who this might be right for
Cervical Dysplasia
Jhpiego 40
Not applicableUnknownNCT04776915
What this trial is testing

Congenital Uterine Anomalies & Pregnancy in Polycystic Ovarian Syndrome

Who this might be right for
Mullerian Anomaly of Uterus, Nec
Uludag University 100
Testing effectiveness (Phase 2)Study completedNCT00231855
What this trial is testing

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

Who this might be right for
Ovarian NeoplasmsUterine Neoplasms
Montefiore Medical Center 31
Large-scale testing (Phase 3)UnknownNCT05620355
What this trial is testing

Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.

Who this might be right for
Uterine FibroidsHeavy Menstrual Bleeding
Bio Genuine (Shanghai) Biotech Co., Ltd. 312
Testing effectiveness (Phase 2)Study completedNCT00401635
What this trial is testing

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Who this might be right for
Endometrial Cancer
National Cancer Institute, Naples 42
Testing effectiveness (Phase 2)Looking for participantsNCT05758688
What this trial is testing

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Who this might be right for
Cervical CancerUterine CancerEndometrial Cancer
Abramson Cancer Center at Penn Medicine 25
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Not applicableStudy completedNCT00342446
What this trial is testing

A Follow-up Study of Women Evaluated and Treated for Infertility

Who this might be right for
Ovarian CancerBreast CancerEndometrial Cancer+2 more
National Cancer Institute (NCI) 12,193
Not applicableLooking for participantsNCT06448897
What this trial is testing

Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.

Who this might be right for
Cervical CancerLymph Node MetastasisArtificial Intelligence
Obstetrics & Gynecology Hospital of Fudan University 4,000
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Not applicableLooking for participantsNCT07345897
What this trial is testing

Emergency Department-based Cervical Cancer Screening Through Self-sampling

Who this might be right for
HPVHPV Associated CancersHPV Cancers+2 more
University of Rochester 200
Not applicableUnknownNCT06250010
What this trial is testing

Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence

Who this might be right for
Endometrial Cancer
Regina Elena Cancer Institute 30
Early research (Phase 1)UnknownNCT01454479
What this trial is testing

A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma

Who this might be right for
Recurrent Endometrial Cancer
Hung-Hsueh Chou 24
Not applicableUnknownNCT01063296
What this trial is testing

Effects of Chemotherapy on Circulating Tumor Cells and Recurrences in Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Huazhong University of Science and Technology 400
Not applicableLooking for participantsNCT04093388
What this trial is testing

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

Who this might be right for
Cervical Cancer
University of Alabama at Birmingham 250
Load More Results